Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Svane, Kirsten C., Ericka-Kate Asis, Anton Omelchenko, Ansley J. Kunnath, Linda M. Brzustowicz, Steven M. Silverstein, and Bonnie L. Firestein. "D-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner." Molecular and Cellular Neuroscience 89 (2018): 20-32. |
|
Perry, Benjamin I., Rachel Upthegrove, Owen Crawford, Soomin Jang, Edward Lau, Isabelle McGill, Emma Carver, Peter B. Jones, and Golam M. Khandaker. "Cardiometabolic risk prediction algorithms for young people with psychosis: a systematic review and exploratory analysis." Acta Psychiatrica Scandinavica 142, no. 3 (2020): 215-232. |
|
Roper, Leslie J., Scot E. Purdon, and Katherine J. Aitchison. "Childhood and later life stressors and psychosis." Clinical Neuropsychiatry: Journal of Treatment Evaluation (2015). |
|
Steffens, M., C. Neumann, A-M. Kasparbauer, B. Becker, B. Weber, M. A. Mehta, R. Hurlemann, and U. Ettinger. "Effects of ketamine on brain function during response inhibition." Psychopharmacology 235, no. 12 (2018): 3559-3571. |
|
Stojanovic-Pérez, Alexander, Lourdes Martorell, Itziar Montalvo, Laura Ortega, Montse Solé, Irene Moreno, Elisabet Vilella, and Javier Labad. "The relationship between antidepressant treatment and inflammatory markers in early psychosis: preliminary results." Psychopharmacology 233, no. 19 (2016): 3659-3661. |
|
Prisco, Vincenzo, Teresa Iannaccone, Umberto Volpe, and Michele Fabrazzo. "Leucocytosis in clozapine-treated patients as predictor of loss of treatment response?." Case Reports 2015 (2015): bcr2014209148. |
|
Shiga, Tetsuya, Sho Horikoshi, Kazuko Kanno, Keiko Kanno?Nozaki, Masayuki Hikita, Shuntaro Itagaki, Itaru Miura, and Hirooki Yabe. "Plasma levels of dopamine metabolite correlate with mismatch negativity in patients with schizophrenia." Psychiatry and clinical neurosciences 74, no. 5 (2020): 289-293. |
|
Hao, Keke, X. I. Su, Binbin Luo, Yaqi Cai, Tengfei Chen, Yongfeng Yang, Minglong Shao et al. "Prenatal immune activation induces age-related alterations in rat offspring: Effects upon NMDA receptors and behaviors." Behavioural brain research 370 (2019): 111946. |
|
Polat, Asl?han, U?ur �akir, and Nermin Gündüz. "Leukocytosis after clozapine treatment in a patient with chronic schizophrenia." Nöro Psikiyatri Ar?ivi 53, no. 1 (2016): 87. |
|
Dauvermann, Maria R., Thomas WJ Moorhead, Andrew R. Watson, Barbara Duff, Liana Romaniuk, Jeremy Hall, Neil Roberts et al. "Verbal working memory and functional large-scale networks in schizophrenia." Psychiatry Research: Neuroimaging 270 (2017): 86-96. |
|
Montalvo, Itziar, Alexandre González-Rodríguez, Ángel Cabezas, Alfonso Gutiérrez-Zotes, Montse Solé, Maria José Algora, Laura Ortega et al. "Glycated Haemoglobin Is Associated With Poorer Cognitive Performance in Patients With Recent-Onset Psychosis." Frontiers in Psychiatry 11 (2020): 455. |
|
Hegde, Mahabaleshwar V., and Arundhati A. Saraph. "Unstable genes unstable mind: beyond the central dogma of molecular biology." Medical hypotheses 77, no. 2 (2011): 165-170. |
|
Liu, Fong, Nahla Mahgoub, and Stephen Ferrando. "Leukocytosis associated with clozapine treatment: a case report." Psychosomatics 52, no. 5 (2011): 488-491. |
|
Venero, César. "Pharmacological treatment of cognitive dysfunction in neuropsychiatric disorders." In Cognitive Enhancement, pp. 233-271. Academic Press, 2015. |
|
Jakobsen, M. I., J. R. Larsen, C. K. Svensson, S. S. Johansen, K. Linnet, Jimmi Nielsen, and A. Fink?Jensen. "The significance of sampling time in therapeutic drug monitoring of clozapine." Acta Psychiatrica Scandinavica 135, no. 2 (2017): 159-169. |
|
Fabrazzo, Michele, Vincenzo Prisco, Gaia Sampogna, Francesco Perris, Francesco Catapano, Alessio Maria Monteleone, and Mario Maj. "Clozapine versus other antipsychotics during the first 18 weeks of treatment: a retrospective study on risk factor increase of blood dyscrasias." Psychiatry research 256 (2017): 275-282. |
|
Klasik, Adam, Krzysztof Krysta, Marek Krzystanek, and Katarzyna Ska?acka. "Impact of olanzapine on cognitive functions in patients with schizophrenia during an observation period of six months." Psychiatr Danub 23, no. suppl 1 (2011): S83-S86. |
|
Raja, Michele, and Silvia Raja. "Clozapine safety, 40 years later." Current drug safety 9, no. 3 (2014): 163-195. |
|
Miller, Brian J., and Peter F. Buckley. "Medical and Psychiatric Comorbidities: Complicating Treatment Expectations." In Treatment–Refractory Schizophrenia, pp. 45-63. Springer, Berlin, Heidelberg, 2014. |
|